HRA Pharma Granted European Marketing Authorization For EllaOne(R) – Next Generation Emergency Contraceptive

May 30, 2009 by admin 

HRA Pharma, a privately-held, European pharmaceutical company that designs products, devices and supporting services in reproductive health and endocrinology, announced today that ellaOne(R) (ulipristal acetate), its next generation emergency contraceptive, has been granted marketing authorization by the European Commission.

Source: HRA Pharma Granted European Marketing Authorization For EllaOne(R) – Next Generation Emergency Contraceptive

Comments

Feel free to leave a comment...
and oh, if you want a pic to show with your comment, go get a gravatar!





Security Code: